Differences Between Self-Reported Psychotic Experiences, Clinically Relevant Psychotic Experiences, and Attenuated Psychotic Symptoms in the General Population

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorMORIYAMA, Tais Silveira
dc.contributor.authorOS, Jim van
dc.contributor.authorGADELHA, Ary
dc.contributor.authorPAN, Pedro Mario
dc.contributor.authorSALUM, Giovanni Abrahao
dc.contributor.authorMANFRO, Gisela Gus
dc.contributor.authorMARI, Jair de Jesus
dc.contributor.authorMIGUEL, Euripedes Constantino
dc.contributor.authorROHDE, Luis Augusto
dc.contributor.authorPOLANCZYK, Guilherme Vanoni
dc.contributor.authorMCGUIRE, Philip
dc.contributor.authorBRESSAN, Rodrigo Affonseca
dc.contributor.authorDRUKKER, Marian
dc.date.accessioned2020-01-21T15:12:13Z
dc.date.available2020-01-21T15:12:13Z
dc.date.issued2019
dc.description.abstractPurpose: Psychotic experiences in childhood (such as hearing voices or being suspicious) represent an important phenotype for early intervention. However, these experiences can be defined in several ways: self-reported psychotic experiences (SRPE) rely exclusively on the child's report, clinically validated psychotic experiences (CRPE) are based on clinical assessment, and attenuated psychotic symptoms (APS) represents a categorization to do with clinical relevance in relation to severity. Very few studies have investigated how these distinctions impact clinical and other domains. The present study aims to compare SRPE, CRPE, and APS among children and adolescents. Methods: This study is part of the Brazilian High-Risk Cohort Study for Psychiatric Disorders, in which 2,241 individuals aged 6-14 years provided self-ratings of 20 psychotic experiences using the Community Assessment of Psychic Experiences (CAPE). A trained psychologist conducted an interview to validate or reject reported experiences and to rate the presence of APS and affective flattening. In parallel, parents provided information about child mental health to an independent interviewer. We tested the association of mutually exclusive categories of non-validated SRPE (nSRPE), clinically validated PE below the threshold for APS (nCRPE), and APS (nSRPE = 33%, nCRPE = 11%, APS = 6%), with parents' information about the child's positive attributes and levels of psychopathology and psychologist assessment of blunted affect. Results: Most associations were qualitatively similar, and there was a dose-response in the strength of associations across categories, such that APS > nCRPE > nSRPE. Experiences in all three categories were associated with female sex. nSRPE were associated with overall levels of psychopathology, but to a lesser degree than nCRPE and APS. APS and nCRPE were associated with less positive attributes, with APS more so than nCRPE. Only APS was associated with affective flattening. Conclusions: In children and adolescents, SRPE, CRPE, and APS all index liability for psychopathology, but as clinician rated relevance increases, associations get stronger and become evident across more domains.eng
dc.description.indexPubMedeng
dc.description.sponsorshipNational Institute of Developmental Psychiatry for Children and Adolescents, a science and technology institute - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq
dc.description.sponsorshipNational Council for Scientific and Technological Development)National Council for Scientific and Technological Development (CNPq) [573974/20080]
dc.description.sponsorshipFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP
dc.description.sponsorshipResearch Support Foundation of the State of Sao Paulo)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/57896-8]
dc.description.sponsorshipEuropean Community's Seventh Framework ProgramEuropean Union (EU) [HEALTH-F2-2009-241909]
dc.description.sponsorshipCNPqNational Council for Scientific and Technological Development (CNPq)
dc.description.sponsorshipFAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
dc.description.sponsorshipCoordenacao de Aperfeicoamentode Pessoal de Nivel Superior (CAPES)CAPES
dc.description.sponsorshipFundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS
dc.description.sponsorshipResearch Support Foundation from the State of Rio Grande do Sul)
dc.description.sponsorshipCAPESCAPES [10553/12-6]
dc.description.sponsorshipCAPESCAPES
dc.description.sponsorshipCNPq/CAPESNational Council for Scientific and Technological Development (CNPq)CAPES
dc.description.sponsorshipCAPES/FAPERGSCAPESFoundation for Research Support of the State of Rio Grande do Sul (FAPERGS)
dc.description.sponsorshipCNPq scholarshipNational Council for Scientific and Technological Development (CNPq) [302463/2011-9, 310582/2017-2]
dc.identifier.citationFRONTIERS IN PSYCHIATRY, v.10, article ID 782, 13p, 2019
dc.identifier.doi10.3389/fpsyt.2019.00782
dc.identifier.issn1664-0640
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/34521
dc.language.isoeng
dc.publisherFRONTIERS MEDIA SAeng
dc.relation.ispartofFrontiers in Psychiatry
dc.rightsopenAccesseng
dc.rights.holderCopyright FRONTIERS MEDIA SAeng
dc.subjectpsychotic experienceseng
dc.subjectattenuated psychotic symptomseng
dc.subjectadolescentseng
dc.subjectschizophreniaeng
dc.subjectpsychiatric epidemiologyeng
dc.subject.otherhigh-risk stateseng
dc.subject.othercommunity sampleeng
dc.subject.otherschizophreniform disordereng
dc.subject.otherpsychometric propertieseng
dc.subject.otherpsychiatric-disorderseng
dc.subject.otherpositive attributeseng
dc.subject.otherepa guidanceeng
dc.subject.otherfollow-upeng
dc.subject.otherchildreneng
dc.subject.otheradolescentseng
dc.subject.wosPsychiatryeng
dc.titleDifferences Between Self-Reported Psychotic Experiences, Clinically Relevant Psychotic Experiences, and Attenuated Psychotic Symptoms in the General Populationeng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.affiliation.countryInglaterra
hcfmusp.affiliation.countryHolanda
hcfmusp.affiliation.countryisonl
hcfmusp.affiliation.countryisogb
hcfmusp.author.externalMORIYAMA, Tais Silveira:Inst Bairral Psiquiatria, Ctr Atendimento Especializado, Itapira, Brazil; Univ Fed Sao Paulo, Dept Psychiat, Sao Paulo, Brazil; CNPq, INCT, Natl Inst Dev Psychiat Children & Adolescents, Brazilian High Risk Cohort Study Psychiat Disorde, Sao Paulo, Brazil; MUMC, Sch Mental Hlth & Neurosci MHeNS, Dept Psychiat & Psychol, Maastricht, Netherlands
hcfmusp.author.externalOS, Jim van:MUMC, Sch Mental Hlth & Neurosci MHeNS, Dept Psychiat & Psychol, Maastricht, Netherlands; Kings Coll London, Kings Hlth Partners, Dept Psychosis Studies, London, England; Univ Utrecht, Med Ctr, UMC Utrecht Brain Ctr, Dept Psychiat, Utrecht, Netherlands
hcfmusp.author.externalGADELHA, Ary:Univ Fed Sao Paulo, Dept Psychiat, Sao Paulo, Brazil; CNPq, INCT, Natl Inst Dev Psychiat Children & Adolescents, Brazilian High Risk Cohort Study Psychiat Disorde, Sao Paulo, Brazil
hcfmusp.author.externalPAN, Pedro Mario:Univ Fed Sao Paulo, Dept Psychiat, Sao Paulo, Brazil; CNPq, INCT, Natl Inst Dev Psychiat Children & Adolescents, Brazilian High Risk Cohort Study Psychiat Disorde, Sao Paulo, Brazil
hcfmusp.author.externalSALUM, Giovanni Abrahao:CNPq, INCT, Natl Inst Dev Psychiat Children & Adolescents, Brazilian High Risk Cohort Study Psychiat Disorde, Sao Paulo, Brazil; Univ Fed Rio Grande do Sul, Dept Psychiat, Porto Alegre, RS, Brazil
hcfmusp.author.externalMANFRO, Gisela Gus:CNPq, INCT, Natl Inst Dev Psychiat Children & Adolescents, Brazilian High Risk Cohort Study Psychiat Disorde, Sao Paulo, Brazil; Univ Fed Rio Grande do Sul, Dept Psychiat, Porto Alegre, RS, Brazil
hcfmusp.author.externalMARI, Jair de Jesus:Univ Fed Sao Paulo, Dept Psychiat, Sao Paulo, Brazil; CNPq, INCT, Natl Inst Dev Psychiat Children & Adolescents, Brazilian High Risk Cohort Study Psychiat Disorde, Sao Paulo, Brazil
hcfmusp.author.externalROHDE, Luis Augusto:CNPq, INCT, Natl Inst Dev Psychiat Children & Adolescents, Brazilian High Risk Cohort Study Psychiat Disorde, Sao Paulo, Brazil; Univ Fed Rio Grande do Sul, Dept Psychiat, Porto Alegre, RS, Brazil
hcfmusp.author.externalMCGUIRE, Philip:Kings Coll London, Kings Hlth Partners, Dept Psychosis Studies, London, England
hcfmusp.author.externalBRESSAN, Rodrigo Affonseca:Univ Fed Sao Paulo, Dept Psychiat, Sao Paulo, Brazil; CNPq, INCT, Natl Inst Dev Psychiat Children & Adolescents, Brazilian High Risk Cohort Study Psychiat Disorde, Sao Paulo, Brazil; MUMC, Sch Mental Hlth & Neurosci MHeNS, Dept Psychiat & Psychol, Maastricht, Netherlands
hcfmusp.author.externalDRUKKER, Marian:MUMC, Sch Mental Hlth & Neurosci MHeNS, Dept Psychiat & Psychol, Maastricht, Netherlands
hcfmusp.citation.scopus19
hcfmusp.contributor.author-fmusphcEURIPEDES CONSTANTINO MIGUEL FILHO
hcfmusp.contributor.author-fmusphcGUILHERME VANONI POLANCZYK
hcfmusp.description.articlenumber782
hcfmusp.description.volume10
hcfmusp.origemWOS
hcfmusp.origem.pubmed31736802
hcfmusp.origem.scopus2-s2.0-85074983870
hcfmusp.origem.wosWOS:000496145500001
hcfmusp.publisher.cityLAUSANNEeng
hcfmusp.publisher.countrySWITZERLANDeng
hcfmusp.relation.reference[Anonymous], 2013, STAT STAT SOFTW RELeng
hcfmusp.relation.referenceArmando M, 2010, SCHIZOPHR RES, V119, P258, DOI 10.1016/j.schres.2010.03.001eng
hcfmusp.relation.referenceBak M, 2003, SCHIZOPHR RES, V62, P187, DOI 10.1016/S0920-9964(02)00336-5eng
hcfmusp.relation.referenceBarragan M, 2011, EUR PSYCHIAT, V26, P396, DOI 10.1016/j.eurpsy.2010.12.007eng
hcfmusp.relation.referenceBarragan M, 2011, PSYCHIAT RES, V186, P225, DOI 10.1016/j.psychres.2010.07.051eng
hcfmusp.relation.referenceBartels-Velthuis AA, 2011, BRIT J PSYCHIAT, V199, P296, DOI 10.1192/bjp.bp.110.086918eng
hcfmusp.relation.referenceBordin IA, 2013, CAD SAUDE PUBLICA, V29, P13, DOI 10.1590/S0102-311X2013000100004eng
hcfmusp.relation.referenceCannon M, 2002, ARCH GEN PSYCHIAT, V59, P449, DOI 10.1001/archpsyc.59.5.449eng
hcfmusp.relation.referenceClemmensen L, 2016, PSYCHOL MED, V46, P87, DOI 10.1017/S0033291715001567eng
hcfmusp.relation.referenceDe Loore E, 2011, SCHIZOPHR RES, V127, P252, DOI 10.1016/j.schres.2011.01.015eng
hcfmusp.relation.referenceDominguez MDG, 2010, AM J PSYCHIAT, V167, P1075, DOI 10.1176/appi.ajp.2010.09060883eng
hcfmusp.relation.referenceFALLON T, 1994, J CHILD PSYCHOL PSYC, V35, P1391, DOI 10.1111/j.1469-7610.1994.tb01282.xeng
hcfmusp.relation.referenceFC A., 2013, IARIW IBGE C INC WEAeng
hcfmusp.relation.referenceFigueiredo VLM, 2001, ADAPTACAO BRASILEIRAeng
hcfmusp.relation.referenceFleitlich-Bilyk B, 2004, J AM ACAD CHILD PSY, V43, P727, DOI 10.1097/01.chi.0000120021.14101.caeng
hcfmusp.relation.referenceFusar-Poli P, 2013, ACTA PSYCHIAT SCAND, V127, P248, DOI 10.1111/acps.12028eng
hcfmusp.relation.referenceGoodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1111/j.1469-7610.2000.tb02345.xeng
hcfmusp.relation.referenceGoodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015eng
hcfmusp.relation.referenceHoffmann MS, 2016, J AM ACAD CHILD PSY, V55, P47, DOI 10.1016/j.jaac.2015.10.013eng
hcfmusp.relation.referenceHorwood J, 2008, BRIT J PSYCHIAT, V193, P185, DOI 10.1192/bjp.bp.108.051904eng
hcfmusp.relation.referenceJolley S, 2018, BRIT J CLIN PSYCHOL, V57, P328, DOI 10.1111/bjc.12176eng
hcfmusp.relation.referenceKaymaz N, 2012, PSYCHOL MED, V42, P2239, DOI 10.1017/S0033291711002911eng
hcfmusp.relation.referenceKelleher I, 2012, PSYCHOL MED, V42, P1857, DOI 10.1017/S0033291711002960eng
hcfmusp.relation.referenceKelleher I, 2012, BRIT J PSYCHIAT, V201, P26, DOI 10.1192/bjp.bp.111.101543eng
hcfmusp.relation.referenceKelleher I, 2015, SCHIZOPHR RES, V165, P9, DOI 10.1016/j.schres.2015.03.020eng
hcfmusp.relation.referenceKelleher I, 2013, JAMA PSYCHIAT, V70, P940, DOI 10.1001/jamapsychiatry.2013.140eng
hcfmusp.relation.referenceKelleher I, 2011, SCHIZOPHRENIA BULL, V37, P362, DOI 10.1093/schbul/sbp057eng
hcfmusp.relation.referenceKelleher I, 2010, BRIT J PSYCHIAT, V197, P167, DOI 10.1192/bjp.bp.109.076018eng
hcfmusp.relation.referenceKonings M, 2006, ACTA PSYCHIAT SCAND, V114, P55, DOI 10.1111/j.1600-0447.2005.00741.xeng
hcfmusp.relation.referenceKring AM, 2008, SCHIZOPHRENIA BULL, V34, P819, DOI 10.1093/schbul/sbn071eng
hcfmusp.relation.referenceLaurens KR, 2012, PSYCHOL MED, V42, P1495, DOI 10.1017/S0033291711002108eng
hcfmusp.relation.referenceLaurens KR, 2007, SCHIZOPHR RES, V90, P130, DOI 10.1016/j.schres.2006.11.006eng
hcfmusp.relation.referenceLee KW, 2016, EARLY INTERV PSYCHIA, V10, P3, DOI 10.1111/eip.12228eng
hcfmusp.relation.referenceLinscott RJ, 2013, PSYCHOL MED, V43, P1133, DOI 10.1017/S0033291712001626eng
hcfmusp.relation.referenceMark W, 2016, SCHIZOPHRENIA BULL, V42, P34, DOI 10.1093/schbul/sbv088eng
hcfmusp.relation.referenceMCGORRY PD, 1995, ACTA PSYCHIAT SCAND, V92, P241, DOI 10.1111/j.1600-0447.1995.tb09577.xeng
hcfmusp.relation.referenceMiklowitz DJ, 2014, J AM ACAD CHILD PSY, V53, P848, DOI 10.1016/j.jaac.2014.04.020eng
hcfmusp.relation.referenceMossaheb N, 2012, SCHIZOPHR RES, V141, P210, DOI 10.1016/j.schres.2012.08.008eng
hcfmusp.relation.referenceNational Institute for Health and Care Excellence, 2013, PSYCH SCHIZ CHILDR Yeng
hcfmusp.relation.referencePesquisa ABdEd, 2010, CRIT CLASS EC BRASeng
hcfmusp.relation.referencePolanczyk G, 2010, ARCH GEN PSYCHIAT, V67, P328, DOI 10.1001/archgenpsychiatry.2010.14eng
hcfmusp.relation.referencePoulton R, 2000, ARCH GEN PSYCHIAT, V57, P1053, DOI 10.1001/archpsyc.57.11.1053eng
hcfmusp.relation.referencePoulton R, 2014, J AM ACAD CHILD PSY, V53, P1279, DOI 10.1016/j.jaac.2014.08.014eng
hcfmusp.relation.referenceSalum GA, 2015, INT J METH PSYCH RES, V24, P58, DOI 10.1002/mpr.1459eng
hcfmusp.relation.referenceSchimmelmann BG, 2012, EUR CHILD ADOLES PSY, V21, P239, DOI 10.1007/s00787-012-0271-zeng
hcfmusp.relation.referenceSchmidt SJ, 2015, EUR PSYCHIAT, V30, P388, DOI 10.1016/j.eurpsy.2015.01.013eng
hcfmusp.relation.referenceSchultze-Lutter F, 2015, EUR PSYCHIAT, V30, P405, DOI 10.1016/j.eurpsy.2015.01.010eng
hcfmusp.relation.referenceSchultze-Lutter F, 2014, PSYCHOPATHOLOGY, V47, P194, DOI 10.1159/000355554eng
hcfmusp.relation.referenceSchwabStone ME, 1996, J AM ACAD CHILD PSY, V35, P878, DOI 10.1097/00004583-199607000-00013eng
hcfmusp.relation.referenceScott J, 2009, SCHIZOPHR RES, V107, P179, DOI 10.1016/j.schres.2008.11.002eng
hcfmusp.relation.referenceSikich L, 2013, CHILD ADOL PSYCH CL, V22, P655, DOI 10.1016/j.chc.2013.06.005eng
hcfmusp.relation.referenceSimon AE, 2014, SCHIZOPHR RES, V159, P292, DOI 10.1016/j.schres.2014.09.016eng
hcfmusp.relation.referenceSnijders T., 1999, MULTILEVEL ANAL INTReng
hcfmusp.relation.referenceStefanis NC, 2002, PSYCHOL MED, V32, P347, DOI 10.1017/S0033291701005141eng
hcfmusp.relation.referenceTELLEGEN A, 1967, J CONSULT PSYCHOL, V31, P499, DOI 10.1037/h0024963eng
hcfmusp.relation.referencevan Nierop M, 2012, SCHIZOPHRENIA BULL, V38, P231, DOI 10.1093/schbul/sbr129eng
hcfmusp.relation.referencevan Os J, 2016, WORLD PSYCHIATRY, V15, P118, DOI 10.1002/wps.20310eng
hcfmusp.relation.referencevan Os J, 2009, LANCET, V374, P635, DOI 10.1016/S0140-6736(09)60995-8eng
hcfmusp.relation.referenceVidal-Ribas P, 2015, BRIT J PSYCHIAT, V206, P17, DOI 10.1192/bjp.bp.114.144519eng
hcfmusp.relation.referenceWechsler D, 2002, WISC 3 ESCALA INT WE, V3aeng
hcfmusp.relation.referenceWeissman MM, 2000, ARCH GEN PSYCHIAT, V57, P675, DOI 10.1001/archpsyc.57.7.675eng
hcfmusp.relation.referenceWigman JTW, 2011, SCHIZOPHRENIA BULL, V37, P850, DOI 10.1093/schbul/sbp154eng
hcfmusp.relation.referenceWoods SW, 2018, SCHIZOPHRENIA BULL, V44, P254, DOI 10.1093/schbul/sbx138eng
hcfmusp.relation.referenceYung AR, 2009, AUST NZ J PSYCHIAT, V43, P118, DOI 10.1080/00048670802607188eng
hcfmusp.relation.referenceYung AR, 2005, AUST NZ J PSYCHIAT, V39, P964, DOI 10.1080/j.1440-1614.2005.01714.xeng
hcfmusp.relation.referenceYung AR, 1996, AUST NZ J PSYCHIAT, V30, P587, DOI 10.3109/00048679609062654eng
hcfmusp.relation.referenceYung AR, 2003, SCHIZOPHR RES, V60, P21, DOI 10.1016/S0920-9964(02)00167-6eng
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublication587b0a62-5611-4071-ae48-19a46c43b55d
relation.isAuthorOfPublication107c1ba9-764d-461e-aa8d-0dee86ca590e
relation.isAuthorOfPublication.latestForDiscovery587b0a62-5611-4071-ae48-19a46c43b55d
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
art_MORIYAMA_Differences_Between_SelfReported_Psychotic_Experiences_Clinically_Relevant_Psychotic_2019.PDF
Tamanho:
985.47 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - FM/MPS
Artigos e Materiais de Revistas Científicas - LIM/23